Related Experiment Video
Updated: Jul 31, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Percutaneous Left Atrial Appendage Closure: Supporting Evidence, Limitations and Future Directions
Giuseppe Imperatore1, Stijn Lochy2, Mohamed Ben Yedder3
1Health Science Interdisciplinary Centre, Sant'Anna School of Advanced Studies, 56127 Pisa, Italy.
Insights
Percutaneous Left Atrial Appendage Occlusion (LAAO) offers a stroke prevention alternative for atrial fibrillation patients unable to use anticoagulants. This review evaluates LAAO
Area of Science:
- Cardiology
- Interventional Cardiology
- Medical Device Technology
Background:
- Atrial fibrillation (AF) poses a significant stroke risk, often managed with anticoagulation.
- Long-term anticoagulation is contraindicated for some AF patients.
- Percutaneous Left Atrial Appendage Occlusion (LAAO) has emerged as an alternative stroke prevention strategy.
Purpose of the Study:
- To comprehensively review the efficacy and safety of the LAAO procedure.
- To consolidate existing evidence from clinical trials and real-world studies.
- To identify limitations in current LAAO research and outline future directions.
Main Methods:
- Systematic review of published clinical trials and real-world data on LAAO.
- Analysis of procedural success rates, safety outcomes, and long-term efficacy.
- Evaluation of patient selection criteria, procedural techniques, and follow-up protocols.
Main Results:
- LAAO demonstrates promising efficacy in stroke prevention for select AF patients.
- Safety profiles are generally favorable, with specific procedural risks identified.
- Variability exists in patient selection, techniques, and follow-up, impacting outcome interpretation.
Conclusions:
- LAAO is a viable stroke prevention option for patients with contraindications to anticoagulation.
- Further research is needed to standardize protocols and optimize patient selection.
- Addressing current knowledge gaps will enhance the therapeutic potential of LAAO.
Abstract:
Percutaneous Left Atrial Appendage Occlusion (LAAO) has emerged as a promising intervention for stroke prevention in patients with atrial fibrillation who are contraindicated for long-term anticoagulation therapy. Despite its growing adoption, a comprehensive review of the LAAO procedure is essential to consolidate the supporting evidence, identify limitations, and outline future directions. This review aims to evaluate the efficacy and safety of LAAO, drawing on clinical trials and real-world studies to provide a balanced perspective. Additionally, we address the limitations of current research, including variability in patient selection, procedural techniques, and follow-up protocols. By highlighting gaps in the knowledge and areas for improvement, this review aims to guide future research efforts to optimize and expand the therapeutic potential of LAAO.
More Related Videos
Related Concept Videos
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cardiac Catheterization II: Right Heart Catheterization
Cardiac Catheterization III: Left Heart Catheterization
Mitral Regurgitation I: Introduction
Mitral Stenosis I: Introduction
Mitral Stenosis II: Clinical features and Diagnostic Tests

